Francisco R M Laurindo Selected Research

S-nitroso-N-acetylcysteine

4/2008	Prevention and reversion of nonalcoholic steatohepatitis in OB/OB mice by S-nitroso-N-acetylcysteine treatment.
3/2006	Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francisco R M Laurindo Research Topics

Disease

5	Thrombosis (Thrombus) 01/2018 - 03/2016
5	Neointima 01/2017 - 12/2003
3	Neoplasms (Cancer) 01/2020 - 03/2003
3	Fibrosis (Cirrhosis) 01/2018 - 10/2003
3	Vascular Remodeling 12/2017 - 01/2017
3	Vascular Diseases (Vascular Disease) 01/2011 - 06/2008
3	Non-alcoholic Fatty Liver Disease 04/2008 - 10/2003
2	Myocardial Infarction 01/2020 - 01/2015
2	Reperfusion Injury 01/2018 - 02/2006
2	Atherosclerosis 01/2018 - 07/2012
2	Body Weight (Weight, Body) 09/2010 - 05/2010
2	Hyperhomocysteinemia 09/2010 - 08/2006
1	Melanoma (Melanoma, Malignant) 09/2021
1	Weight Gain 12/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Coronary Occlusion 01/2020
1	Cardiomegaly (Heart Hypertrophy) 01/2018
1	Dengue (Dengue Fever) 01/2016
1	Heart Failure 01/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2014
1	Inflammation (Inflammations) 07/2012
1	Angina Pectoris 01/2012
1	Atherosclerotic Plaque (Atheroma) 12/2011
1	Yellow Fever 03/2011
1	Ventricular Remodeling 01/2011
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 05/2010
1	Coronary Disease (Coronary Heart Disease) 05/2010
1	Infections 10/2009
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2009
1	Vascular Calcification 03/2008
1	Pathologic Constriction (Stenosis) 03/2008
1	Necrosis 03/2006
1	Ileitis 10/2004
1	Crohn Disease (Crohn's Disease) 10/2004
1	Renal Insufficiency (Renal Failure) 07/2004
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2004
1	Vascular System Injuries 03/2004
1	Sepsis (Septicemia) 03/2004

Drug/Important Bio-Agent (IBA)

8	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2021 - 03/2003
7	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2015 - 03/2004
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2006
4	AntioxidantsIBA 01/2017 - 03/2003
3	Protein Disulfide-IsomerasesIBA 12/2017 - 06/2008
3	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 09/2010 - 08/2006
2	Superoxides (Superoxide)IBA 09/2021 - 03/2004
2	Angiotensin IIIBA 01/2018 - 06/2009
2	Sulfhydryl Compounds (Thiols)IBA 01/2018 - 12/2017
2	DisulfidesIBA 01/2017 - 03/2016
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2015 - 07/2004
2	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2012 - 01/2011
2	EnzymesIBA 01/2011 - 03/2004
2	SolutionsIBA 09/2010 - 03/2006
2	homocysteine thiolactoneIBA 09/2010 - 05/2010
2	S-nitroso-N-acetylcysteineIBA 04/2008 - 03/2006
2	Choline (Choline Chloride)IBA 03/2006 - 10/2003
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 10/2003 - 03/2003
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2021
1	BiopterinsIBA 09/2021
1	sapropterin (tetrahydrobiopterin)FDA Link 09/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2020
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	CatalaseIBA 01/2020
1	Superoxide DismutaseIBA 01/2020
1	PeroxiredoxinsIBA 01/2020
1	MelatoninIBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Leflunomide (Arava)FDA LinkGeneric 01/2018
1	IsomerasesIBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 07/2015
1	Proteasome InhibitorsIBA 07/2012
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2012
1	LipidsIBA 12/2011
1	sulfhydryl oxidaseIBA 12/2011
1	SmokeIBA 01/2011
1	Drinking WaterIBA 09/2010
1	Y 27632IBA 09/2010
1	HomocysteineIBA 05/2010
1	Mitochondrial DNA (mtDNA)IBA 06/2009
1	Ethidium (Ethidium Bromide)IBA 06/2009
1	Protein Isoforms (Isoforms)IBA 06/2009
1	tempolIBA 03/2008
1	PeroxidesIBA 03/2008
1	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2006
1	Transaminases (Aminotransferases)IBA 03/2006
1	Fluconazole (Zonal)FDA LinkGeneric 03/2006
1	Oxygen (Dioxygen)IBA 02/2006
1	mitochondrial K(ATP) channelIBA 02/2006
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 10/2004
1	Indomethacin (Indometacin)FDA LinkGeneric 10/2004
1	Oxidants (Oxidizing Agents)IBA 07/2004
1	NADP (NADPH)IBA 03/2004
1	Messenger RNA (mRNA)IBA 12/2003
1	3-nitrotyrosineIBA 12/2003
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2003
1	Vitamin E FDA LinkGeneric 10/2003

Therapy/Procedure

2	Therapeutics 09/2021 - 01/2020
1	Hyperbaric Oxygenation 01/2020
1	Stents 12/2011
1	Oral Administration 03/2006